How I Treat Multiple Myeloma in Relapsed Post-Auto SCT and Role of Brentuximab Vedotin treatment of High Risk HL patients post ASCT

Name: How I Treat Multiple Myeloma in Relapsed Post-Auto SCT and Role of Brentuximab Vedotin treatment of High Risk HL patients post ASCT
Start: 2020-10-04T00:00:00+03:00
End: 2020-10-04T01:00:00+03:00